↓ Skip to main content

Weiterhin keine Evidenz für neoadjuvante Therapie beim Pankreaskarzinom

Overview of attention for article published in Der Chirurg, June 2020
Altmetric Badge

Mentioned by

twitter
1 tweeter
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Weiterhin keine Evidenz für neoadjuvante Therapie beim Pankreaskarzinom
Published in
Der Chirurg, June 2020
DOI 10.1007/s00104-020-01214-7
Pubmed ID
Authors

O. Strobel, M. W. Büchler

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 June 2020.
All research outputs
#13,924,463
of 15,787,724 outputs
Outputs from Der Chirurg
#152
of 256 outputs
Outputs of similar age
#238,765
of 290,789 outputs
Outputs of similar age from Der Chirurg
#3
of 4 outputs
Altmetric has tracked 15,787,724 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 256 research outputs from this source. They receive a mean Attention Score of 3.7. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 290,789 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.